Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze BEAM stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BEAM investment potential.

What is BEAM stock price today?

Get real-time BEAM stock price, historical data, and price charts on Financhill. Track BEAM performance with our advanced analysis tools.

Is BEAM a good investment?

Evaluate BEAM investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BEAM stock?

To buy BEAM stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BEAM?

View detailed market capitalization data and company valuation metrics for BEAM on our comprehensive analysis page.

What is the P/E ratio of BEAM?

Use our fundamental analysis tools to view BEAM P/E ratio and compare valuation metrics with industry peers.

What are BEAM earnings?

View BEAM earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Beam Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

BEAM
Beam Therapeutics, Inc.

Last Price:

$26.92

Seasonality Move:

-33.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Beam Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Beam Therapeutics, Inc. has on average historically fallen by 23.7% based on the past 6 years of stock performance.
Beam Therapeutics, Inc. has fallen lower in 5 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 83.33%
Is Beam Therapeutics, Inc. Stock Undervalued?

The current Beam Therapeutics, Inc. [BEAM] share price is $26.93. The Score for BEAM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
BEAM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Beam Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Beam Therapeutics, Inc. has on average historically fallen by 23.7% based on the past 6 years of stock performance.

Beam Therapeutics, Inc. Stock Rating

Sell

Beam Therapeutics, Inc. (BEAM) is a Sell

Is Beam Therapeutics, Inc. overpriced?

Beam Therapeutics, Inc. has fallen lower in 5 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 83.33%

Beam Therapeutics, Inc. Stock Price History

Is BEAM stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BEAM is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

beamtx.com

52-Week Data

52-Week High:

36.44

52-Week Low:

13.53

Prediction Charts

Market Cap:

2.7B

Price in USD:

26.93

Volume:

Beta:

1.84

Technical Analysis

SMA50:

28.39

SMA100:

26.49

SMA200:

22.54

52-Wk Change:

-5.74%

Stock Predictions

Is Beam Therapeutics, Inc. stock public?

Yes, Beam Therapeutics, Inc. is a publicly traded company.
What is the Beam Therapeutics, Inc. stock quote today?

The Beam Therapeutics, Inc. stock price is 26.93 USD today.
How to buy Beam Therapeutics, Inc. stock online?

You can buy Beam Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jan-26	31.29	30.95	31.90	30.16
Jan-27	30.91	30.70	32.26	30.32
Jan-28	30.96	29.02	30.97	28.37
Jan-29	28.68	29.29	29.93	28.62
Jan-30	29.00	27.62	29.04	27.44
Feb-2	27.51	27.92	28.48	27.00
Feb-3	27.71	27.89	29.26	27.10
Feb-4	27.72	26.95	27.93	26.05
Feb-5	26.46	24.73	27.04	24.30
Feb-6	25.63	26.52	26.68	25.21
Feb-9	26.45	27.28	27.33	25.79
Feb-10	27.40	26.95	27.86	26.76
Feb-11	26.97	25.99	27.20	25.23
Feb-12	26.09	26.93	27.02	25.69

Beam Therapeutics, Inc. Earnings

Beam Therapeutics, Inc. Earnings Report: Per Share Beam Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Beam Therapeutics, Inc. Forecast Revenue Growth

Beam Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.34 per share, and an increase next year of $0.04 per share.

* Beam Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.